From Pellet to Pack-out: When to Use Vertically Integrated (VI) Drug Delivery Solutions
Sponsored by: Flex
- Drug Delivery
- Vertical Integration
Date: 18 October
Days to go: 27
Time: 3PM London/10AM New York
In our ever-changing healthcare environment, the pressures from economics, accessibility, patent protection and integration into a digital world present new challenges to Pharma beyond those previously prevalent. These challenges create their own risks and pose both commercial, technical and logistical issues that may best be solved by taking a holistic view of the drug delivery solution in a vertically integrated approach. The ideal state is a “pellet to pack-out” solution that maximizes supply chain and production efficiencies and minimizes their risks. Achieving that requires identifying and addressing all of those challenges and risks.
This webinar identifies the requirements to fulfil a vertically integrated solution for a drug delivery platform within the drug delivery ecosystem. It demonstrates a total risk management approach and draws on lessons learned from practical experience, showing how pharma companies can:
- Decrease supply chain disruptions with less reliance on multiple individual suppliers
- Improve traceability and documentation under a holistic quality management system for combination products
- Achieve consistent, controlled quality across the entire supply chain and manufacturing process
- Control design customization and proactive change management
- Lower total cost and leverage economies of scale
When achieved, Vertical Integration can de-risk product supply and can create value at each phase of the product lifecycle. Sign up for this free webinar and learn how to achieve VI for your drug delivery platform.
Mark Lee, PhD,
CTO Flex - Health Solutions
Dr. Mark Lee is the Chief Technology Officer for the Health Solutions group at Flex Ltd. where he drives innovation and excellence within the medical business, focusing on Sketch-to-Scale™ solutions. This extends from defining user needs through human-factors through innovation and design, to ramp up, full scale production, and supply chain management. Prior to Flex, Dr. Lee was the Global Head of R&D for J&J where he led research and development activities across the pharmaceutical, medical device and consumer health segments of the company. Dr. Lee also held leadership roles in R&D with fortune 100 medical device companies including Baxter, GE medical and Amgen, where he developed the combination product design process for all of Amgen’s pipeline molecules.
Dr. Lee holds a PhD in Engineering Science from the University of Western Ontario, Canada and a Master of Science, and Bachelor’s Degree in Engineering Science from the University of Toronto, Canada.